ALPMY

Astellas Pharma (PK) (ALPMY)

Astellas Pharma Inc (PK)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:ALPMY

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/12/16	07 : 53	Dow Jones News	Merck, Pfizer, Astellas Get FDA OK For Expanded Use Of Keytruda Plus Padcev	USOTC:ALPMY	Astellas Pharma Inc (PK)
2023/12/01	08 : 04	Dow Jones News	Astellas, Seagen: Cancer Treatment Padcev Supplemental Biologics License Application Gets FDA Priority Review	USOTC:ALPMY	Astellas Pharma Inc (PK)
2023/09/22	20 : 02	Dow Jones News	Merck, Seagen, Astellas Phase 3 Bladder Cancer Study Hits Endpoints	USOTC:ALPMY	Astellas Pharma Inc (PK)
2023/08/07	23 : 41	Dow Jones News	Poseida Therapeutics Shares Leap on Astellas Investments	USOTC:ALPMY	Astellas Pharma Inc (PK)
2023/08/07	22 : 58	Dow Jones News	Poseida Therapeutics in $50 Million Investment Deal With Astellas	USOTC:ALPMY	Astellas Pharma Inc (PK)
2023/05/01	09 : 57	Dow Jones News	Astellas Pharma to Buy Iveric Bio for About $5.9 Billion	USOTC:ALPMY	Astellas Pharma Inc (PK)
2023/01/10	00 : 49	Dow Jones News	Selecta Biosciences Shares Rise 11% After Licensing Deal With Astellas Pharma	USOTC:ALPMY	Astellas Pharma Inc (PK)
2022/10/25	19 : 26	Dow Jones News	Taysha Gene Therapies Shares Soar Premarket on Astellas Investment	USOTC:ALPMY	Astellas Pharma Inc (PK)
2022/06/28	23 : 28	Dow Jones News	Sutro Biopharma Shares Rise 24% After Collaboration With Astellas Pharma	USOTC:ALPMY	Astellas Pharma Inc (PK)
2022/06/28	09 : 37	Dow Jones News	Sutro Biopharma Shares Soar 67% on Cancer Treatment Collaboration with Astellas	USOTC:ALPMY	Astellas Pharma Inc (PK)
2022/04/14	01 : 31	Dow Jones News	European Commission Approves Drug for Urothelial Cancer	USOTC:ALPMY	Astellas Pharma Inc (PK)
2021/12/17	21 : 37	Dow Jones News	Astellas Pharma, Seagen Get CHMP Positive Opinion for Padcev	USOTC:ALPMY	Astellas Pharma Inc (PK)
2021/08/11	20 : 54	Dow Jones News	FDA Rejects FibroGen's Roxadustat for Anemia of Chronic Kidney Disease	USOTC:ALPMY	Astellas Pharma Inc (PK)
2017/12/22	06 : 17	Edgar (US Regulatory)	Securities Registration (ads, Immediate) (f-6ef)	USOTC:ALPMY	Astellas Pharma Inc (PK)
2017/09/30	02 : 03	Edgar (US Regulatory)	Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)	USOTC:ALPMY	Astellas Pharma Inc (PK)
2016/08/22	21 : 50	Dow Jones News	Pfizer Adds Key Cancer Drug in $14 Billion Biotech Deal	USOTC:ALPMY	Astellas Pharma Inc (PK)
2016/07/09	16 : 02	Dow Jones News	Corrections & Amplifications -- WSJ	USOTC:ALPMY	Astellas Pharma Inc (PK)
2016/07/07	14 : 20	Dow Jones News	Test Aids Prostate Cancer Treatment	USOTC:ALPMY	Astellas Pharma Inc (PK)
2016/06/02	07 : 40	Dow Jones News	Sanofi Asks for Record Date for Vote on Medivation's Board	USOTC:ALPMY	Astellas Pharma Inc (PK)
2016/04/29	07 : 10	Dow Jones News	Drugmakers Place Big Bets on Cancer Medicines	USOTC:ALPMY	Astellas Pharma Inc (PK)
2016/03/29	23 : 50	Dow Jones News	Lawmakers Target Medivation Over Drug Prices	USOTC:ALPMY	Astellas Pharma Inc (PK)
2015/12/05	06 : 03	The Motley Fool	Ocata Therapeutics Almost Doubled in November -- Here's Why	USOTC:ALPMY	Astellas Pharma Inc (PK)
2015/11/25	23 : 04	The Motley Fool	Johnson & Johnson's Latest FDA Approval Could Spell Problems for Amgen	USOTC:ALPMY	Astellas Pharma Inc (PK)
2015/11/24	00 : 07	The Motley Fool	3 Value Stocks Near 52-Week Lows Worth Buying	USOTC:ALPMY	Astellas Pharma Inc (PK)
2015/11/07	02 : 40	The Motley Fool	Medivation Inc is Down Today -- But Why?	USOTC:ALPMY	Astellas Pharma Inc (PK)
2015/11/02	21 : 34	The Motley Fool	3 Stocks to Buy Now in Biotech	USOTC:ALPMY	Astellas Pharma Inc (PK)
2015/07/16	03 : 33	Dow Jones News	Asian Shares: China Stocks Tumble as Investors Doubt Beijing's Help	USOTC:ALPMY	Astellas Pharma Inc. ADR
2015/03/22	20 : 01	The Motley Fool	Best One-Drug Wonder Stock for 2015	USOTC:ALPMY	Astellas Pharma Inc (PK)
2015/01/30	13 : 30	Dow Jones News	Valeant to Buy Prostate-Cancer Drug From Dendreon	USOTC:ALPMY	Astellas Pharma Inc. ADS
2015/01/30	13 : 10	Dow Jones News	Valeant in Deal to Buy Prostate-Cancer Drug Provenge From Dendreon	USOTC:ALPMY	Astellas Pharma Inc. ADS